Diffuse large B-cell lymphoma
M Martelli, AJM Ferreri, C Agostinelli, A Di Rocco… - Critical reviews in …, 2013 - Elsevier
Diffuse large B-cell lymphoma (DLBCL) is the most common lymphoid malignancy in adults
accounting for 31% of all NHL in Western Countries. Following, morphological, biological …
accounting for 31% of all NHL in Western Countries. Following, morphological, biological …
Allogeneic hematopoietic cell transplantation: the state of the art
B Gyurkocza, A Rezvani, RF Storb - Expert review of hematology, 2010 - Taylor & Francis
Allogeneic hematopoietic cell transplantation (HCT) is a potentially curative procedure for a
variety of hematologic malignancies. The field has evolved substantially over the past …
variety of hematologic malignancies. The field has evolved substantially over the past …
Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine …
IF Khouri, P McLaughlin, RM Saliba… - Blood, The Journal …, 2008 - ashpublications.org
Nonmyeloablative stem cell transplantation in patients with follicular lymphoma has been
designed to exploit the graft-versus-lymphoma immunity. The long-term effectiveness and …
designed to exploit the graft-versus-lymphoma immunity. The long-term effectiveness and …
Outcomes after allogeneic hematopoietic cell transplantation with nonmyeloablative or myeloablative conditioning regimens for treatment of lymphoma and chronic …
ML Sorror, BE Storer, DG Maloney… - Blood, The Journal …, 2008 - ashpublications.org
Allogeneic conventional hematopoietic cell transplantation (HCT) can be curative treatment
for lymphoid malignancies, but it has been characterized by high nonrelapse mortality …
for lymphoid malignancies, but it has been characterized by high nonrelapse mortality …
Conditioning regimens for allotransplants for diffuse large B-cell lymphoma: myeloablative or reduced intensity?
U Bacher, E Klyuchnikov… - Blood, The Journal …, 2012 - ashpublications.org
The best conditioning regimen before allogeneic transplantation for high-risk diffuse large B-
cell lymphoma (DLBCL) remains to be clarified. We analyzed data from 396 recipients of …
cell lymphoma (DLBCL) remains to be clarified. We analyzed data from 396 recipients of …
Nonmyeloablative allogeneic hematopoietic cell transplantation in relapsed, refractory, and transformed indolent non-Hodgkin's lymphoma
AR Rezvani, B Storer, M Maris, ML Sorror… - Journal of clinical …, 2008 - ascopubs.org
Purpose Few effective treatment options exist for chemotherapy-refractory indolent or
transformed non-Hodgkin's lymphoma (NHL). We examined the outcome of …
transformed non-Hodgkin's lymphoma (NHL). We examined the outcome of …
[HTML][HTML] The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of diffuse large B cell lymphoma: update of the 2001 evidence-based …
DM Oliansky, M Czuczman, RI Fisher, FD Irwin… - Biology of blood and …, 2011 - Elsevier
Clinical research published since the 2001 evidence-based review on the role of
hematopoietic stem cell transplantation (SCT) in the treatment of diffuse large B cell …
hematopoietic stem cell transplantation (SCT) in the treatment of diffuse large B cell …
Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: a GITMO study
L Rigacci, B Puccini, A Dodero, P Iacopino… - Annals of …, 2012 - Springer
Patients who relapse after an autologous hematopoietic stem cell transplantation (SCT)
have a very poor prognosis. We have retrospectively analyzed diffuse large B cell lymphoma …
have a very poor prognosis. We have retrospectively analyzed diffuse large B cell lymphoma …
[HTML][HTML] Low nonrelapse mortality and prolonged long-term survival after reduced-intensity allogeneic stem cell transplantation for relapsed or refractory diffuse large …
A Sirvent, N Dhedin, M Michallet, N Mounier… - Biology of Blood and …, 2010 - Elsevier
Patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) have a very poor
prognosis. However, they may achieve long-term survival by undergoing allogeneic stem …
prognosis. However, they may achieve long-term survival by undergoing allogeneic stem …
[HTML][HTML] Autologous versus reduced-intensity allogeneic hematopoietic cell transplantation for patients with chemosensitive follicular non-Hodgkin lymphoma beyond …
MR Tomblyn, M Ewell, C Bredeson, BS Kahl… - Biology of Blood and …, 2011 - Elsevier
Patients with follicular lymphoma (FL) typically experience an indolent course; however, the
disease is rarely curable with conventional chemotherapy. Autologous hematopoietic cell …
disease is rarely curable with conventional chemotherapy. Autologous hematopoietic cell …